Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells
- PMID: 9571172
- DOI: 10.1006/bbrc.1998.8454
Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells
Abstract
Vascular endothelial growth factor (VEGF) stimulates nitric oxide (NO) production by endothelial cells in vitro and in vivo. However, the impact of VEGF on inducible nitric oxide synthase (iNOS) activity and NO synthesis in cultured mesangial cells is not known. Therefore, we measured nitrite accumulation in cytokine-stimulated, rat mesangial cells (RMC) in response to graded concentrations of VEGF. Addition of VEGF (10-50 ng/ml) did not alter RMC viability or NO production in either normal (5.6 mM) or high (33.3 mM) glucose conditions. Exposure of RMC to VEGF did not modify the effects of L-arginine (20 mM) or L-NAME (1 mM) on nitrite accumulation in normal or high glucose media. The steady state abundance of iNOS mRNA and the cytosolic content of iNOS protein were unaffected by addition of VEGF. Cultured RMC expressed the high-affinity tyrosine kinase VEGF receptors, flt and flk/KDR, and the levels were not modulated by incubation in normal or high glucose media. We conclude that VEGF does not regulate proliferation or NO production in cultured RMC. These findings suggest that disturbances in the normal interaction between VEGF and NO are not involved in the pathogenesis of abnormal mesangial cell structure or function in diabetic nephropathy.
Similar articles
-
Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.Lab Invest. 1997 Jun;76(6):779-91. Lab Invest. 1997. PMID: 9194854
-
Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):367-74. Biochem J. 1999. PMID: 10024512 Free PMC article.
-
A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.Biochem Biophys Res Commun. 1999 Nov 30;265(3):636-9. doi: 10.1006/bbrc.1999.1729. Biochem Biophys Res Commun. 1999. PMID: 10600473
-
Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.Am J Physiol Renal Physiol. 2007 Jun;292(6):F1665-72. doi: 10.1152/ajprenal.00495.2006. Am J Physiol Renal Physiol. 2007. PMID: 17545302 Review.
-
Nitric oxide and adverse events of vascular endothelial growth factor inhibitors.Curr Med Res Opin. 2011 Aug;27(8):1503-7. doi: 10.1185/03007995.2011.590970. Epub 2011 Jun 9. Curr Med Res Opin. 2011. PMID: 21651424 Review.
Cited by
-
Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.J Endocrinol Invest. 1999 Oct;22(9):708-35. doi: 10.1007/BF03343635. J Endocrinol Invest. 1999. PMID: 10595837 Review. No abstract available.
-
Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein.Pediatr Nephrol. 2006 May;21(5):619-26. doi: 10.1007/s00467-006-0066-x. Epub 2006 Mar 25. Pediatr Nephrol. 2006. PMID: 16565872
-
VEGF(165) mediates glomerular endothelial repair.J Clin Invest. 1999 Oct;104(7):913-23. doi: 10.1172/JCI6740. J Clin Invest. 1999. PMID: 10510332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources